Leerink Partners analyst Pasha Sarraf reiterated an Outperform rating and $118.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE